The Role of RIG-I in Fighting Influenza A Virus
Learn how RIG-I helps our immune system combat influenza A virus.
Elizaveta Elshina, Emmanuelle Pitre, Marisa Mendes, Brandon Schweibenz, Hollie French, Ji Woo Park, Wei Wang, Joseph Marcotrigiano, Alistair B. Russell, Aartjan J.W. te Velthuis
― 5 min read
Table of Contents
Influenza A virus (IAV) is the pesky little gremlin that often shows up uninvited during flu season. When it enters our bodies, our immune system, specifically the innate immune response, kicks in to defend us. This response can either help us fight off the virus or, sometimes, it can go a bit overboard and create a "Cytokine Storm," which is like throwing a party where no one knows when to leave.
One of the heroes in this battle is a protein called RIG-I. Think of RIG-I as a virus detective. Its job is to recognize when the influenza virus is causing trouble. However, the details of how RIG-I figures out the virus's sneaky moves are still somewhat of a mystery.
How RIG-I Detects the Virus
RIG-I is best friends with a special kind of RNA called double-stranded RNA (dsRNA), which is known to be quite the troublemaker during IAV infections. When IAV starts replicating, it uses its own RNA, which is not exactly like the RNA our cells usually use. During an infection, RIG-I can bind to certain ends of the viral RNA, which helps it detect the virus.
But wait! There's more. Not all RNA pieces are created equal. Some viral RNA pieces, like defective viral genomes (DVG) or mini viral RNAs (mvRNA), can still trigger RIG-I’s alarm bell, while others, like small viral RNAs (svRNA), just don’t cut it. This makes the whole immune response a bit tricky because not every viral RNA is an equal opportunity troublemaker.
A Sneaky Trick: Capped cRNAs
Sometimes, during its operation, the IAV RNA polymerase, which is a crucial player in viral replication, can produce a special type of RNA called capped cRNA. This caps off the RNA molecules, making them look a little different from the standard viral RNA. This cRNA is produced in a way where it has a cap on one end and a unique tail on the other, making it non-canonical, which is just a fancy way of saying it's a bit weird.
Now, here's the twist: when there is a mutation in the RNA polymerase (let's call it the T677A mutation), it can boost the production of these capped cRNAs. This mutation acts like a friend who accidentally spills the beans at a party, leading to even more capped cRNAs being made.
Capped cRNAs and the Immune Response
These capped cRNAs are like secret agents. They can be detected by RIG-I, especially when they form pairs with complementary viral RNA. When RIG-I recognizes these pairs, it triggers an immune response and helps alert the rest of the immune system, making sure the virus doesn’t have a smooth ride.
However, it’s not just about making capped cRNAs. The environment matters too. The RNA polymerase needs to be in the right spot and at the right time to produce these capped cRNAs. If everything lines up nicely, the immune response can kick into high gear and help fight off the virus.
What Happens During an Infection?
When IAV infects a cell, it first makes its way into the nucleus, the control center of the cell. There, it releases its viral RNA and starts producing proteins that are essential for its life cycle. The virus tricks the cell into making more of its RNA, which can then be used to create new virus particles.
In the center of this viral showdown, the viral polymerase is hard at work. As it churns out RNA, some of this RNA can become capped cRNAs, which RIG-I detects. This detection is essential because if RIG-I can recognize the virus early on, it can help activate further Immune Responses, like producing interferons, which are like alarm bells for other immune cells.
The Good, The Bad, and The Ugly of cRNA Production
While capped cRNAs play an important role in signaling that the virus is around, producing too many of them can confuse the immune system. It’s like a fire alarm going off when someone just burnt toast. There’s a balance to strike. Too much alarm can lead to a chaotic immune response, which can be detrimental.
The flu virus, being the cunning little rascal it is, has evolved various strategies to outsmart the immune system, even using some of its own tricks against it. The interplay between the virus and our immune system is a constant tug-of-war-a game of cat and mouse, where sometimes the cat wins, and sometimes the mouse gets away.
Conclusion: The Ongoing Battle Against Influenza
In essence, our bodies are in a constant battle against the influenza virus. The virus uses clever tactics to replicate and spread, while our immune system deploys its own set of heroes, like RIG-I, to detect and respond to the threat. Understanding how these interactions work not only helps us appreciate the complexity of our immune response but also guides researchers in developing better vaccines and treatments against the flu.
As we head into another flu season, it’s always a good idea to roll up your sleeves for a flu shot and prep your immune system for the ongoing battle. After all, in the war against viruses, being informed is your best defense!
Title: Influenza A virus transcription generates capped cRNAs that activate RIG-I
Abstract: During influenza A virus (IAV) infection, host pathogen receptor retinoic acid-inducible gene I (RIG-I) detects the partially complementary, 5'-triphosphorylated ends of the viral genome segments and non-canonical replication products. However, it has also been suggested that innate immune responses may be triggered by viral transcription. In this study, we investigated whether an immunostimulatory RNA is produced during IAV transcription. We show that the IAV RNA polymerase can read though the polyadenylation signal during transcription termination, generating a capped complementary RNA (ccRNA), which contains the 5' cap of an IAV mRNA and the 3' terminus of a cRNA instead of a poly(A) tail. ccRNAs are detectable in vitro and in both ribonucleoprotein reconstitution assays and IAV infections. Mutations that disrupt polyadenylation enhance ccRNA synthesis and increase RIG-I-dependent innate immune activation. Notably, while ccRNA itself is not immunostimulatory, it forms a RIG-I agonist by hybridizing with a complementary negative-sense viral RNA. These findings thus identify a novel non-canonical IAV RNA species and suggest an alternative mechanism for RIG-I activation during IAV infection.
Authors: Elizaveta Elshina, Emmanuelle Pitre, Marisa Mendes, Brandon Schweibenz, Hollie French, Ji Woo Park, Wei Wang, Joseph Marcotrigiano, Alistair B. Russell, Aartjan J.W. te Velthuis
Last Update: 2024-12-03 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.11.12.623191
Source PDF: https://www.biorxiv.org/content/10.1101/2024.11.12.623191.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.